NanoViricides, Inc. (NNVC.PK) Reports Novel Drug Candidates For Treatment Of The MERS (Middle East Respiratory Syndrome) Corona Virus Ready For Animal Testing
5/5/2014 8:56:54 AM
WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company") reported today that it has designed and synthesized novel nanoviricides® drug candidates in quantities sufficient for testing in animals infected with the MERS Corona Virus.
Help employers find you! Check out all the jobs and post your resume.
comments powered by